Effects of EPA Supplementation on Patients With Unresectable Hepatocellular Carcinoma.

NCT07664007 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

18

Enrollment

OTHER

Sponsor class

Conditions

Hepatocellular Carcinoma

Interventions

DIETARY_SUPPLEMENT: Eicosapentaenoic acid oral lipidic emulsion
DIETARY_SUPPLEMENT: Pacebo oral lipidic emulsion

Sponsor

Instituto de Investigación Sanitaria Aragón

Collaborators

[object Object]
[object Object]